We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




New Ultrasound Technology Prevents Brain Damage in Newborns Undergoing Surgery

By HospiMedica International staff writers
Posted on 03 Jan 2024

Premature and critically ill newborns undergoing surgery are more susceptible to brain injuries during general anesthesia due to possible variations in blood pressure. More...

Now, a breakthrough ultrasound technology that allows for real-time monitoring of cerebral blood flow in newborns aims to prevent brain damage in premature and sick infants undergoing surgery.

The new ultrasound technology named NeoDoppler has been developed by researchers at the Norwegian University of Science and Technology (NTNU, Trondheim, Norway) for continuous measurements of cerebral blood flow in neonates. NeoDoppler is designed to reduce the occurrence of brain injuries in premature and critically ill newborns by providing vital data on their cerebral blood flow, allowing for timely interventions when needed. By detecting fluctuations in cerebral blood flow, caregivers can make critical adjustments, such as fine-tuning ventilator settings or managing blood pressure, to avert potential brain damage. The device, shaped like a button, is gently positioned on the infant's head, where it can continuously monitor blood flow through the open fontanelle without disrupting the child, medical care, or parental interaction.

NeoDoppler's operation is not dependent on the user, setting it apart from traditional ultrasound imaging that offers only a snapshot of the brain circulation. During a two-year study, researchers employed this method on 30 newborns, including extremely premature infants and those born with congenital anomalies. Findings indicated a notable drop in cerebral blood flow speed under anesthesia, suggesting that current blood pressure standards for newborns might be too low, thereby increasing their risk during surgeries. The research team envisions NeoDoppler becoming a new norm in newborn monitoring, with potential applications extending to a wide array of pediatric patients, such as those with congenital heart diseases or other neonatal surgical needs.

Related Links:
NTNU


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Autoclave
Advance
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.